Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Lung Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06208124
What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more
Immuneering Corporation 30
Not applicableStudy completedNCT04960059
What this trial is testing

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

Who this might be right for
CancerMetastatic MelanomaRenal Cell Carcinoma+1 more
The Christie NHS Foundation Trust 24
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Looking for participantsNCT07348211
What this trial is testing

First in Human Study of SIM0610 in Solid Tumors

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more
Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Large-scale testing (Phase 3)Study completedNCT01828112
What this trial is testing

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 231
Testing effectiveness (Phase 2)Study completedNCT00006877
What this trial is testing

Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT00513266
What this trial is testing

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
Centre Hospitalier Universitaire Vaudois 35
Testing effectiveness (Phase 2)Study completedNCT00006483
What this trial is testing

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

Who this might be right for
Kidney CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Ended earlyNCT06974734
What this trial is testing

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

Who this might be right for
Carcinoma, Non Small Cell LungCarcinoma, Pancreatic DuctalMalignant Melanoma+1 more
Pfizer 8
Early research (Phase 1)Ended earlyNCT02376699
What this trial is testing

Safety Study of SEA-CD40 in Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellHodgkin Disease+17 more
Seagen Inc. 159
Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Testing effectiveness (Phase 2)Ended earlyNCT04161391
What this trial is testing

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerRET Gene Mutation+2 more
Turning Point Therapeutics, Inc. 41
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Early research (Phase 1)Looking for participantsNCT04999761
What this trial is testing

AB122 Platform Study

Who this might be right for
Advanced or Metastatic Solid TumorPancreatic Ductal AdenocarcinomaColorectal Cancer+6 more
Taiho Pharmaceutical Co., Ltd. 917
Testing effectiveness (Phase 2)WithdrawnNCT05566223
What this trial is testing

CISH Inactivated TILs in the Treatment of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungMetastatic Non Small Cell Lung CancerStage IV Non-small Cell Lung Cancer+3 more
Intima Bioscience, Inc.
Not applicableLooking for participantsNCT07636148
What this trial is testing

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Who this might be right for
Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer Metastatic+10 more
Mark C Burgmans, MD PhD 2,000
Testing effectiveness (Phase 2)Study completedNCT00043368
What this trial is testing

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Who this might be right for
MelanomaBreast NeoplasmsCarcinoma, Renal Cell+2 more
Pfizer 31
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Testing effectiveness (Phase 2)Study completedNCT00027638
What this trial is testing

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+1 more
Memorial Sloan Kettering Cancer Center
Next Page